Ad Code

Molecular Diagnostics Market Share & Global Forecast, By Application - Renub Research

Renub ResearchRenub Research March 02, 2020
There are various reasons that will propel the market growth in forecast year; rising incidence rate of infectious disease, increasing incidence rate of cancer of all type, increasing people awareness regarding molecular diagnostic, rapid technological growth, widely acceptance of personalized medicine, rising healthcare infrastructure, increasing healthcare per capita expenditure across the developed and developing nation, accuracy of diagnosis, growing population of cardiovascular and neurological disorder, etc. In addition, increasing the prevalence of genetic disorders will further boost the market in the forecast period of time.



Increasing prevalence of infectious diseases such as Influenza, HPV, Hepatitis, HIV, and Tuberculosis despite the rise in sanitation practices globally. In the past, antimicrobials medicines were used to fight powerful infectious disease but slowly in today's time antimicrobial agent is not able to give the desired results because the problem of drug-resistant occurs in many people across the world. Nowadays, a new diagnostic procedure is being followed to fight infectious diseases like molecular diagnostic tests is very effective which is quite fast and precise. The number of cancer patients is increasing very fast, so it is believed that in the coming time the molecular diagnostic test market will be growing at a rapid pace. Global Molecular Diagnostics Market is likely to surpass US$ 22.5 Billion by the end of the year 2025.

Renub Research report titled “Molecular Diagnostics Market Share & Forecast, By Application (Infectious Diseases, Blood Screening, Oncology, Genetic Testing, HLA (Tissue Typing), Microbiology, Cardiovascular Diseases, Neurological Diseases, Pharmacogenomics, and Others), By Technology (PCR, Transcription-Mediated Amplification (TMA), Hybridization (In-situ Hybridization & FISH), DNA Sequencing & NGS, Microarray and Others), By End User (Hospitals & Academic Laboratories, Clinics and Commercial Laboratories, Others), By Regions [United States, Europe (Expect Russia), India, China, Japan, Brazil, South Korea, Mexico, Russia, and ROW], Companies (Roche, Abbott, Myriad Genetics, Qiagen, BioMérieux and Others)” provides a complete analysis of Molecular Diagnostics Market.


Market Insight by Application

The report provides a comprehensive analysis of molecular diagnostic test market by application into ten parts: Infectious Diseases, Genetic Testing, Blood Screening, Oncology, HLA (Tissue Typing), Microbiology, Neurological Diseases, Pharmacogenomics, Cardiovascular Diseases, and Others. This report also provides key opportunities market and specific factors are given by each application market.

Market Insight by Technology

Here the market is fragmented into six parts; PCR, Transcription-Mediated Amplification (TMA), Hybridization (In-situ Hybridization & FISH), DNA Sequencing & NGS, Microarray and Others. Besides, many factors have analyzed that influence the growth, challenges, and opportunities of the market in a technological context.

Market Insight by End User

The report provides a complete insight into the market by End User segments: Hospitals & Academic Laboratories, Clinics & Commercial Laboratories and Others. According to Renub Research Analysis, Hospitals & Academic Laboratories will hold the largest market in the global molecular diagnostic test market in the forecast period of time.

Market Insight by Regions

This report covers the complete regional profile by 10 geographical markets; the United States, Europe, India, China, Japan, Brazil, South Korea, Mexico, Russia and the Rest of the World (ROW).

By Application

•    Infectious Diseases
•    Blood Screening
•    Oncology
•    Genetic Testing
•    HLA (Tissue Typing)
•    Microbiology
•    Cardiovascular Diseases
•    Neurological Diseases
•    Pharmacogenomics
•    Others

By Technology

•    PCR
•    Transcription-Mediated Amplification (TMA)
•    Hybridization (In-situ Hybridization & FISH)
•    DNA Sequencing & NGS
•    Microarray
•    Others

By End-User

•    Hospitals & Academic Laboratories
•    Clinics & Commercial Laboratories
•    Others

By Regions

•    United States
•    Europe (Expect Russia)
•    India
•    China
•    Japan
•    Brazil
•    South Korea
•    Mexico
•    Russia
•    Rest of World


About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises of major players in Life Sciences, Information Technology, Telecom, Financial Services (Banking, Insurance), Energy, Retail, Manufacturing, Automotive, and Social sector. Our clients rely on our market analysis and data to make informed knowledgeable decisions. We are regarded as one of the best providers of knowledge. Our pertinent analysis helps consultants, bankers, and executives to make informed and correct decisions.

Contact Us:
Renub Research
Phone No: +1 678-302-0700 (USA) | +91-120-421-9822 (IND)
Renub Research Infographic Zone: https://renubresearchinfographiczone.blogspot.com/
Reactions

Post a Comment

0 Comments

Post a Comment